1[1]Hildebrant B,Wust P,Ahlers O,et al.The cellular and molecular basis of hyperthermia [J].Crit Rev Oncol Hematol,2002,43(1):33-56.
2[2]Urano M,Ling CC.Thermal enhancement of melphalan and oxaliplatin cytotoxicity in vitro [J].Int J Hyperthermia,2002,18(4):307-315.
3[3]Takemoto M,Kuroda M,Urano M,et al.The effect of various chemotherapeutic agents given with mild hyperthermia on different types of tumours[J].Int J Hyperthermia,2003,19 (2):193-203.
4[4]Mohamed F,Marchettini P,Stuart OA,et al.Thermal enhancement of new chemotherapeutic agents at moderate hyperthermia [J].Ann Surg Oncol,2003,10(4):463-468.
5[5]Sagowski C,Jaehne M,Kehrl W,et al.Tumor oxygenation under combined whole-body-hyperthemia and polychemotherapy in a case of recurrent carcinoma of the oral cavity[J].Eur Arch Otorhinolaryngol,2002,259(1):27-31.
6[6]Urano M,Ling CC.Thermal enhancement of melphalan and oxaliplatin cytotoxicity in vitro [J].Int J Hyperthermia,2002,18(4):307-315.
7[7]Siddik ZH.Cisplatin:mode of cytotoxic action and molecular basis of resistance [J].Oncogene,2003,22 (47):7265-7279.
8[8]Baguley BC,Wilson WR.Potential Of DMXAA combination therapy for solid tumors [J].Expert Rev Anticancer Ther,2002,2 (5):593-603.
9[9]Hegewish-Becker S,Braun K,Otte M,et al.Effects of whole body hyperthermia (41.8 degrees C) on the frequenly of tumor cells in the peripheral blood of patients with advanced malignancies [J].Clin Cancer Res,2003,9(6):2079-2084.
10[10]Varma MV,Ashokraj Y,Dey CS,et al.P-glycoprotein inhibitors and their screening:a perspective from bioavailability enhancement [J].Pharmacol Res,2003,48 (4):347-359.
